COVID-19 vaccine; strategic science and technology forces; policy suggestions
Strategy & Policy Decision Research
Strengthening strategic science and technology forces is the key to achieve scientific and technological self-reliance and self-improvement. China's COVID-19 vaccine research and development has achieved a stage success and such success has inseparable relationship with the national strategic science and technology forces. This paper starts from the current situation of COVID-19 vaccine R&D in China and in the world, further considers and explores the mission positioning, top-level design, and strengthening methods of China's strategic science and technology forces, and proposes corresponding policy suggestions on strengthening China's strategic science and technology force, through analyzing the successful experience of China's COVID-19 vaccine R&D.
Bulletin of Chinese Academy of Sciences
1 白春礼. 强化国家战略科技力量. 中国人大, 2021, (7):29-31.
2 胡颖廉. 协同应对未知:国家疫苗产能储备制度构建探析. 中国行政管理, 2020, (5):26-31.
3 张佳星. 中国新冠疫苗研发国际领跑,底气来自哪儿. 科技日报, 2020-07-07(08).
4 胡颖廉. 新冠疫苗研发,中国为何全球领先. 光明日报, 2021-01-07(16).
"Construction of China’s Strategic Science and Technology Forces from Research and Development of COVID-19 Vaccine,"
Bulletin of Chinese Academy of Sciences (Chinese Version): Vol. 36
, Article 14.
Available at: https://bulletinofcas.researchcommons.org/journal/vol36/iss6/14